Gene · 54363
NIH grants701
NIH projects whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 701
Download this page as JSON| Project | Title | Its papers about the gene | Newest fiscal year |
|---|---|---|---|
| P30DK116074 | Stanford Diabetes Research Center | 1 | 2025 |
| P30DK124723 | North Carolina Diabetes Research Center | 1 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 1 | 2025 |
| P30ES019776 | HERCULES: Exposome Research Center | 1 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 1 | 2025 |
| P30GM133893 | Center for Biomolecular Structure (CBMS) | 1 | 2025 |
| P42ES027707 | The MIT Superfund Research Program: A Systems Approach for the Protection of Human Health from Hazardous Chemicals | 1 | 2025 |
| R01AA018873 | Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration | 1 | 2025 |
| R01AI083640 | Regulatory Network of the Lyme Disease Pathogen | 1 | 2025 |
| R01AR080416 | ENPP1 regulation of mammalian bone mass | 1 | 2025 |
| R01CA142746 | Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines | 1 | 2025 |
| R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 1 | 2025 |
| R01CA257558 | Drug eluting injectable biomaterials for next generation chemoembolization | 1 | 2025 |
| R01CA258314 | Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer | 1 | 2025 |
| R01CA261691 | anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals | 1 | 2025 |
| R01DE032302 | Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues | 1 | 2025 |
| R01DK060581 | Transcriptional and Translational Mechanisms Governing Beta Cell Function | 1 | 2025 |
| R01DK080714 | Microfluidic Devices For Determining Dynamics Of Islets of Langerhans | 1 | 2025 |
| R01DK116548 | Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria | 1 | 2025 |
| R01DK124906 | Polyamines and Hypusine in Type 1 Diabetes Pathogenesis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.1.0
Sources 11
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNone stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GeneNone named. Public domain as US government information
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54363/grants?page=3